Release Date: 25/05/09 17:29 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 12.24KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%